Cloning and characterization of human tissue inhibitor of metalloproteinases-3. 1994

C G Wilde, and P R Hawkins, and R T Coleman, and W B Levine, and A M Delegeane, and P M Okamoto, and L Y Ito, and R W Scott, and J J Seilhamer
Incyte Pharmaceuticals Inc., Palo Alto, CA 94304, USA.

The tissue inhibitors of metalloproteinases (TIMPs) comprise a family of proteins, of which two members have so far been described in humans. We have cloned and sequenced a third human TIMP (hTIMP-3) from phorbol ester-differentiated THP-1 cells stimulated with bacterial lipopolysaccharide. The open reading frame encodes a 211-amino-acid precursor including a 23-residue secretion signal. The mature polypeptide has a calculated molecular weight of 21.6 kD and includes an N-linked glycosylation site near the carboxyl terminus. The protein is quite basic, having a predicted isoelectric point of 9.04. We have mapped the single gene encoding human TIMP-3 to chromosome 22. By Northern analysis, transcripts for TIMP-3 were identified in a broad cross-section of tissues examined from both embryonic and adult origin. In all tissues except the placenta, the predominant transcript was 5.0 kb in size, with minor bands around 2.4 and 2.6 kb comprising no more than about 10% of the signal. In the placenta, the smaller bands accounted for close to 50% of the signal. Human TIMP-3 shows slightly closer amino acid sequence similarity to TIMP-2 (44.3%) than to TIMP-1 (38.4%), but is most closely related to a recently reported chicken TIMP, chIMP-3 (80.8% amino acid; 77.7% nucleic acid similarity.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008666 Metalloendopeptidases ENDOPEPTIDASES which use a metal such as ZINC in the catalytic mechanism. Metallo-Endoproteinases,Metalloendopeptidase
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA

Related Publications

C G Wilde, and P R Hawkins, and R T Coleman, and W B Levine, and A M Delegeane, and P M Okamoto, and L Y Ito, and R W Scott, and J J Seilhamer
May 1996, Gene,
C G Wilde, and P R Hawkins, and R T Coleman, and W B Levine, and A M Delegeane, and P M Okamoto, and L Y Ito, and R W Scott, and J J Seilhamer
October 1996, The Journal of biological chemistry,
C G Wilde, and P R Hawkins, and R T Coleman, and W B Levine, and A M Delegeane, and P M Okamoto, and L Y Ito, and R W Scott, and J J Seilhamer
December 1995, Genome research,
C G Wilde, and P R Hawkins, and R T Coleman, and W B Levine, and A M Delegeane, and P M Okamoto, and L Y Ito, and R W Scott, and J J Seilhamer
January 1994, Genomics,
C G Wilde, and P R Hawkins, and R T Coleman, and W B Levine, and A M Delegeane, and P M Okamoto, and L Y Ito, and R W Scott, and J J Seilhamer
April 1998, Gene,
C G Wilde, and P R Hawkins, and R T Coleman, and W B Levine, and A M Delegeane, and P M Okamoto, and L Y Ito, and R W Scott, and J J Seilhamer
January 2003, Advances in experimental medicine and biology,
C G Wilde, and P R Hawkins, and R T Coleman, and W B Levine, and A M Delegeane, and P M Okamoto, and L Y Ito, and R W Scott, and J J Seilhamer
November 1996, The Journal of biological chemistry,
C G Wilde, and P R Hawkins, and R T Coleman, and W B Levine, and A M Delegeane, and P M Okamoto, and L Y Ito, and R W Scott, and J J Seilhamer
April 1990, Proceedings of the National Academy of Sciences of the United States of America,
C G Wilde, and P R Hawkins, and R T Coleman, and W B Levine, and A M Delegeane, and P M Okamoto, and L Y Ito, and R W Scott, and J J Seilhamer
January 2001, Biochimica et biophysica acta,
C G Wilde, and P R Hawkins, and R T Coleman, and W B Levine, and A M Delegeane, and P M Okamoto, and L Y Ito, and R W Scott, and J J Seilhamer
January 1992, Connective tissue research,
Copied contents to your clipboard!